Solventum Corporation

NYSE:SOLV

Medical - Care Facilities

Healthcare
$86.48 -2.61%

-$2.00 today

Market cap
$14.70B
Beta
0.75
P/E (TTM)
9.1
EPS (TTM)
$8.22
52W Low $62.38High $88.20

Volume 0.76M

Average 1.70M

SOLV Interest Income

Income earned on cash, deposits, and investments held by the company.

Solventum CorporationNYSE: SOLV

Interest Income · Q2 FY2026 · quarter ended Jun 2026

Interest income remains negative

Q2 FY2026 interest income was $0, compared with $0 a year earlier. Trailing-twelve-month interest income was $0.

Context

  • Interest income amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Interest income increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly interest income holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMJun 2026
$0— YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Interest Income history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Interest Income vs competitors

How SOLV compares with its peers on the latest reported figures

  • SOLV's LTM Jun 2026 interest income of $0 is the 7th highest of the 10 companies compared; the peer median is $6.99M.
  • Interest income amounts to 0.0% of revenue for SOLV, versus a peer median of 0.2%.
SOLV Competitors Peer median
Interest Income for SOLV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BAXBaxter International Inc.LTM Jun 2026$46M -16.4%+39.9%0.4%
HSICHenry Schein, Inc.LTM Jun 2026$33M +17.9%+24.7%0.2%
BDXBecton, Dickinson and CompanyLTM Sep 2026$27M -28.9%-18.0%0.1%
MMSIMerit Medical Systems, Inc.LTM Sep 2026$15.68M -1.4%+225.0%1.0%
ICUIICU Medical, Inc.LTM Jun 2026$6.99M -37.0%+32.5%0.3%
UTMDUtah Medical Products, Inc.LTM Mar 2026$617K ——1.6%
SOLVSolventum CorporationLTM Jun 2026$0 ——0.0%
COOThe Cooper Companies, Inc.LTM Jul 2026$0 ——0.0%
NVSTEnvista Holdings CorpLTM Oct 2026$0 ——0.0%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding SOLV) $6.99M-16.4%+32.5%0.2%

Competitors are the stored peer set for SOLV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue8.17B8.13B8.2B8.25B8.33B
Cost of Revenue3.25B3.44B3.5B3.66B3.87B
Gross Profit4.92B4.7B4.69B4.59B4.45B
Gross Margin60.2%57.7%57.3%55.6%53.5%
Research & Development766M767M758M775M739M
Selling, General & Admin2.28B2.24B2.24B2.78B3.08B
Operating Expenses3.04B3B3B3.56B2.27B
Depreciation & Amortization597M578M561M555M489M
EBITDA2.48B2.27B2.23B1.53B2.55B
EBITDA Margin30.3%27.9%27.2%18.5%30.6%
Operating Income1.88B1.69B1.69B1.04B2.18B
Operating Margin23.0%20.8%20.6%12.6%26.2%
Interest Income00000
Interest Expense000367M347M
Other Income / Expenses3M(1M)(25M)(431M)(468M)
Income Before Tax1.88B1.69B1.67B605M1.71B
Pre-Tax Margin23.0%20.8%20.3%7.3%20.6%
Income Tax Expense422M349M321M127M157M
Net Income1.46B1.34B1.35B479M1.56B
Net Margin17.9%16.5%16.4%5.8%18.7%
EPS (Basic)8.477.797.792.778.94
EPS (Diluted)8.477.797.792.768.88
Weighted Avg Shares172.47M172.47M172.71M173.2M174.1M
Weighted Avg Shares (Diluted)172.47M172.47M172.71M173.7M175.3M

Solventum Corporation

NYSE:SOLV

Intrinsic Alpha fair value

Locked

Current Price

$86.48

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.